Civilization Ventures Management, Llc — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Biosynthetic Technologies develops innovative solutions in R&D and operations for sustainability-focused applications.
Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsIrvine, US
Allen Barbieri(Executive Officer, Director)inDr. Matt Kriech(CEO)
BoardBernhard Mohr(Director)Meghan Sharp(Director)Kent Wasson(Director)Steve Bierschenk(Director)
Co-investorsHG VenturesAthosGlobal Health Investment CorporationIn-Q-TelSherpalo VenturesViking Global Investors
Curve develops blood tests that use machine-learning models trained on its Whole-Body Atlas, a curated collection of characterized tissue samples, to detect and monitor chronic disease states earlier and more accurately.
AI & Machine LearningBiotechDigital HealthDallas, US
Nathan Hunkapiller(Founder)inProf. Shan Wang, PhD(Chief Innovation Officer and Scientific Founder)Ritish Patnaik, PhD(Chief Executive Officer)CHUBA OYOLU(Executive Officer)SHAN XIANG WANG(Executive Officer, Director)RITISH PATNAIK(Executive Officer, Director)
Co-investorsFirst Spark Ventures, LlcLifeX VenturesLuma GroupNZVCMintaka
Iantrek develops micro-interventional ophthalmic surgical technologies focused on enhancing total outflow through the uveoscleral pathway to treat glaucoma.
BiotechHealthtechMedical DevicesElkins Park, US
Tsontcho Ianchulev(Executive Officer, Director)Sean Ianchulev(Founder & Chairman of the Board (CMO))inMichael Haydin(Executive Officer)
BoardJeffry K Weinhuff(Director)Farrell Tyson(Director)Stephen Bloch(Director)in
Co-investorsaMoonVisionary VenturesCanaan PartnersFemHealth VenturesJSD Capital, LLCUS Venture Partners+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.















